| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 24 |
| 1 | BENDAMUSTINE HCL | 5 |
| 2 | HUMAN IMMUNOGLOBULIN G | 4 |
| 3 | ALBUTEROL SULFATE | 2 |
| 4 | CHLORAMBUCIL | 2 |
| 5 | IBRUTINIB | 2 |
| 6 | MUPIROCIN | 2 |
| 7 | MUPIROCIN CALCIUM | 2 |
| 8 | PREDNISOLONE | 2 |
| 9 | PREDNISOLONE ORAL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORAMBUCIL | 2 | 0.0005 |
| 1 | RITUXIMAB-ABBS | 2 | 0.0004 |
| 2 | BENDAMUSTINE HCL | 5 | 0.0003 |
| 3 | HUMAN IMMUNOGLOBULIN G | 4 | 0.0002 |
| 4 | MUPIROCIN CALCIUM | 2 | 0.0001 |
| 5 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 6 | RITUXIMAB | 24 | 0.0001 |
| 7 | STANDARDIZED SENNA CONCENTRATE | 1 | 0.0001 |
| 8 | ROSUVASTATIN CALCIUM | 1 | 0.0000 |
| 9 | IBRUTINIB | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 1 | RNA Synthetase Inhibitor Antibacterial [EPC] | 2 | 0.0001 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 26 | 0.0001 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 6 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Thiazide Diuretic [EPC] | 1 | 0.0000 |
| 9 | Kinase Inhibitor [EPC] | 2 | 0.0000 |